Petmed Express Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 23 out of 29 in the Food & Drug Retailing industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Sell, with the highest price target at 2.15.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Petmed Express Inc is 7.02, ranking 17 out of 29 in the Food & Drug Retailing industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 40.66M, representing a year-over-year decrease of 23.26%, while its net profit experienced a year-over-year decrease of 1392.64%.
Key Metrics
The current valuation score of Petmed Express Inc is 7.97, ranking 15 out of 29 in the Food & Drug Retailing industry. Its current P/E ratio is -0.72, which is -50563.15% below the recent high of 361.37 and -48441.70% above the recent low of -347.61.
The current earnings forecast score of Petmed Express Inc is 4.00, ranking 20 out of 29 in the Food & Drug Retailing industry. The average price target is 2.75, with a high of 2.75 and a low of 2.75.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Petmed Express Inc is 5.38, ranking 26 out of 29 in the Food & Drug Retailing industry. Currently, the stock price is trading between the resistance level at 2.38 and the support level at 2.14, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Petmed Express Inc is 3.00, ranking 15 out of 29 in the Food & Drug Retailing industry. The latest institutional shareholding proportion is 41.08%, representing a quarter-over-quarter increase of 10.14%. The largest institutional shareholder is James Simons, holding a total of 1.19M shares, representing 5.54% of shares outstanding, with 10.62% decrease in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Drug Retailing domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Petmed Express Inc is 1.35, ranking 27 out of 29 in the Food & Drug Retailing industry. The company's beta value is 0.79. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Petmed Express Inc’s latest ESG disclosure leads the Food & Drug Retailing industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
